Andere talen Paxman AB

Aandelen

PAX

SE0009806284

Vertraagde tijd Nasdaq Stockholm Andere beurzen 15:42:41 27-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
46,4 ^SEK	+1,31%		+3,11%	+26,09%

23/05	Paxman AB (publ) benoemt Karen Giddings Clakely in het bestuur	CI
23/05	Paxman AB (publ) rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Press release from PAXMAN AB’s 2024 Annual General Meeting	23/05
Paxman AB Appoints Karen Giddings Clakely to the Board	23/05
PAXMAN publishes its interim report for Q1 2024	23/05
Paxman AB Reports Earnings Results for the First Quarter Ended March 31, 2024	23/05
Paxman publishes the company’s annual report for 2023	26/04
The shareholders of PAXMAN AB (publ) (”the Company”) are hereby invited to attend the Annual General Meeting on Thursday 23 May 2024 at 12:00 CEST.	19/04
See Redeye's interview with CEO Richard Paxman	23/02
Record year for Paxman!	23/02
Paxman AB Reports Earnings Results for the Full Year Ended December 31, 2023	15/01
Paxman's CEO Richard Paxman in a company presentation at Stora Aktiedagen in Stockholm	29/11
See CEO Richard Paxman presents at Redeye Life Science Day 2023 – 23 November	27/11
See Redeye's interview with CEO Richard Paxman	17/11
PAXMAN publishes its interim report for Q3 2023	17/11
Paxman AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	17/11
Richard Paxman OBE, CEO of Paxman, will join Redeye Life Science Day 2023	10/11
PAXMAN Announces that US Centers for Medicare and Medicaid Services (CMS) continues to support scalp cooling but decreases rate for 2024	07/11
PAXMAN Announces Palmetto GBA Approves First Local Coverage Determination for Scalp Cooling Therapy	03-10-23
PAXMAN Announces Palmetto GBA Approves First Local Coverage Determination for Scalp Cooling Therapy	03-10-23
See Redeye's interview with CEO Richard Paxman	25-08-23
PAXMAN publishes its interim report for Q2 2023	24-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Paxman AB

Aandelen

PAX

SE0009806284

Andere talen

Filters